Market Intellix LLP
  • enquiries@marketintellix[dot]com
  • Sign In
  • Home
  • Industries
    • Healthcare & LifeSciences
    • Chemicals & Materials
    • IT & Telecommunications
    • Automotive & Transportation
    • Food & Beverages
    • Consumer Goods & Retails
    • Packaging & Mining
    • Manufacturing & Construction
  • Industry Reports
  • About Us
  • Clientele
  • Press Releases
  • News
  • Careers
Sign In
  • Home
  • About Us
  • Clientele
  • Industry Reports
  • Custom Research
  • Press Releases
  • News
  • Careers
Browse Categories
  • Healthcare & LifeSciences
  • Chemicals & Materials
  • Healthcare & LifeSciences
  • IT & Telecommunications
  • Automotive & Transportation
  • Healthcare & LifeSciences
  • Food & Beverages
  • Consumer Goods & Retails
  • Manufacturing & Construction
  • Agriculture
  • Energy & Natural Resources
  • Military Aerospace & Defense
  • Home
  • Healthcare & LifeSciences
  • Global PD 1 and PD L1 Drug Industry
Global PD 1 and PD L1 Drug Industry
ID : YHR215904 Category : Healthcare & LifeSciences Pages : 151 Views 130
 

Navigate the Report

Report Overview Research Methodology FAQs
Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized

Quantitative Analysis

  • Market size, estimates, and forecast from 2024 to 2030
  • Market estimates and forecast for product segments up to 2030
  • Regional market size and forecast for product segments up to 2030
  • Market estimates and forecast for application segments up to 2030
  • Regional market size and forecast for application segments up to 2030
  • Company financial performance
  • Home
  • Healthcare & LifeSciences
  • Global PD 1 and PD L1 Drug Industry
Global PD 1 and PD L1 Drug Industry

2023-2029 Global PD-1 and PD-L1 Drug Industry Research & Trends Analysis Report

ID : YHR215904 Category : Healthcare & LifeSciences Pages : 151 Views : 130

Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!

  • DOWNLOAD FREE SAMPLE
  • ENQUIRY BEFORE BUY
  • SECTION PURCHASE

According to Latest Study, the global market for PD-1 and PD-L1 Drug should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China PD-1 and PD-L1 Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States PD-1 and PD-L1 Drug market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, PD-1 Monoclonal Antibody segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Liver Cancer has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of PD-1 and PD-L1 Drug include Bristol Myers Squibb, Merck & Co., Inc., F. Hoffmann -La Roche Ltd, AstraZeneca, Sanofi, Pfizer Inc, Lilly, Novartis AG and GSK, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

PD-1/PD-L1 is an important part of the human immune system-a drug target on T cells. Drugs designed for this target can activate the immune effect of T cells on tumor cells, thereby awakening the patient's own anti-cancer effect. tumor effect.

This report aims to provide a comprehensive study of the global market for PD-1 and PD-L1 Drug. Report Highlights:

(1) Global PD-1 and PD-L1 Drug market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global PD-1 and PD-L1 Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China PD-1 and PD-L1 Drug market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global PD-1 and PD-L1 Drug segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global PD-1 and PD-L1 Drug segment by type and by application and regional segment by type and by application.

(6) Global major production regions of PD-1 and PD-L1 Drug, capacity, production and trends.

(7) PD-1 and PD-L1 Drug industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

PD-1 Monoclonal Antibody

PD-L1 Monoclonal Antibody

Market segment by application, can be divided into

Liver Cancer

Esophageal Cancer

Nasal Cancer

Stomach Cancer

Other

Market segment by players, this report covers

Bristol Myers Squibb

Merck & Co., Inc.

F. Hoffmann -La Roche Ltd

AstraZeneca

Sanofi

Pfizer Inc

Lilly

Novartis AG

GSK

Junshi Biosciences

Akeso, Inc

BeiGene

Innovent

Jiangsu Hengrui Medicine Co.,Ltd

Cstone

Henlius

Simcere Pharmaceutical Group Limited

1 Market Overview

1.1 PD-1 and PD-L1 Drug Definition

1.2 Global PD-1 and PD-L1 Drug Market Size and Forecast

1.2.1 By Revenue, Global PD-1 and PD-L1 Drug Market Size, 2018-2029

1.2.2 By Sales Volume, Global PD-1 and PD-L1 Drug Market Size, 2018-2029

1.2.3 Global PD-1 and PD-L1 Drug Price Trend, 2018-2029

1.3 China PD-1 and PD-L1 Drug Market Size and Forecast

1.3.1 By Revenue, China PD-1 and PD-L1 Drug Market Size, 2018-2029

1.3.2 By Sales Volume, China PD-1 and PD-L1 Drug Market Size, 2018-2029

1.3.3 China PD-1 and PD-L1 Drug Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China PD-1 and PD-L1 Drug Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China PD-1 and PD-L1 Drug Share in Global Market, 2018-2029

1.4.3 PD-1 and PD-L1 Drug Market Size: China VS Global, 2018-2029

1.5 PD-1 and PD-L1 Drug Market Dynamics

1.5.1 PD-1 and PD-L1 Drug Market Drivers

1.5.2 PD-1 and PD-L1 Drug Market Restraints

1.5.3 PD-1 and PD-L1 Drug Industry Trends

1.5.4 PD-1 and PD-L1 Drug Industry Policy

2 Global Competitive Landscape by Company

2.1 Global PD-1 and PD-L1 Drug Revenue by Company, 2018-2023

2.2 Global PD-1 and PD-L1 Drug Sales Volume by Company, 2018-2023

2.3 Global PD-1 and PD-L1 Drug Price by Company, 2018-2023

2.4 Global PD-1 and PD-L1 Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global PD-1 and PD-L1 Drug Concentration Ratio

2.6 Global PD-1 and PD-L1 Drug Mergers & Acquisitions, Expansion Plans

2.7 Global PD-1 and PD-L1 Drug Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China PD-1 and PD-L1 Drug Revenue by Company, 2018-2023

3.2 China PD-1 and PD-L1 Drug Sales Volume by Company, 2018-2023

3.3 China PD-1 and PD-L1 Drug PD-1 and PD-L1 Drug Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China PD-1 and PD-L1 Drug Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, PD-1 and PD-L1 Drug Domestic VS Export

3.6 China Market, PD-1 and PD-L1 Drug Import & Export

3.6.1 China Market, PD-1 and PD-L1 Drug Import & Export, 2018-2029

3.6.2 China PD-1 and PD-L1 Drug Import & Export Trends

3.6.3 Main Sources of China PD-1 and PD-L1 Drug Import

3.6.4 Export Destination of China PD-1 and PD-L1 Drug

4 PD-1 and PD-L1 Drug Production by Region

4.1 Global PD-1 and PD-L1 Drug Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of PD-1 and PD-L1 Drug Manufacturers

4.3 Global Major Manufacturers, PD-1 and PD-L1 Drug Capacity Expansion and Future Plans

4.4 Global PD-1 and PD-L1 Drug Capacity by Region

4.5 Global PD-1 and PD-L1 Drug Production by Region

4.5.1 Global PD-1 and PD-L1 Drug Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global PD-1 and PD-L1 Drug Production by Region, 2018-2023

4.5.3 Global PD-1 and PD-L1 Drug Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 PD-1 and PD-L1 Drug Industry Chain

5.2 PD-1 and PD-L1 Drug Upstream Analysis

5.2.1 PD-1 and PD-L1 Drug Core Raw Materials

5.2.2 Main Manufacturers of PD-1 and PD-L1 Drug Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 PD-1 and PD-L1 Drug Production Mode

5.6 PD-1 and PD-L1 Drug Procurement Model

5.7 PD-1 and PD-L1 Drug Industry Sales Model and Sales Channels

5.7.1 PD-1 and PD-L1 Drug Sales Model

5.7.2 PD-1 and PD-L1 Drug Typical Distributors

6 Sights by Type

6.1 PD-1 and PD-L1 Drug Classification

6.1.1 PD-1 Monoclonal Antibody

6.1.2 PD-L1 Monoclonal Antibody

6.2 By Type, Global PD-1 and PD-L1 Drug Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global PD-1 and PD-L1 Drug Revenue, 2018-2029

6.4 By Type, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029

6.5 By Type, Global PD-1 and PD-L1 Drug Price, 2018-2029

7 Sights by Application

7.1 PD-1 and PD-L1 Drug Segment by Application

7.1.1 Liver Cancer

7.1.2 Esophageal Cancer

7.1.3 Nasal Cancer

7.1.4 Stomach Cancer

7.1.5 Other

7.2 By Application, Global PD-1 and PD-L1 Drug Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global PD-1 and PD-L1 Drug Revenue, 2018-2029

7.4 By Application, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029

7.5 By Application, Global PD-1 and PD-L1 Drug Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global PD-1 and PD-L1 Drug Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global PD-1 and PD-L1 Drug Revenue, 2018-2029

8.3 By Region, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029

8.4 North America

8.4.1 North America PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America PD-1 and PD-L1 Drug Market Size Market Share

8.5 Europe

8.5.1 Europe PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe PD-1 and PD-L1 Drug Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific PD-1 and PD-L1 Drug Market Size Market Share

8.7 South America

8.7.1 South America PD-1 and PD-L1 Drug Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America PD-1 and PD-L1 Drug Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global PD-1 and PD-L1 Drug Market Size & CAGR,2018 VS 2022 VS 2029

9.2 By Country, Global PD-1 and PD-L1 Drug Revenue, 2018-2029

9.3 By Country, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. PD-1 and PD-L1 Drug Market Size, 2018-2029

9.4.2 By Company, U.S. PD-1 and PD-L1 Drug Sales Volume Market Share, 2022

9.4.3 By Type, U.S. PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe PD-1 and PD-L1 Drug Market Size, 2018-2029

9.5.2 By Company, Europe PD-1 and PD-L1 Drug Sales Volume Market Share, 2022

9.5.3 By Type, Europe PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China PD-1 and PD-L1 Drug Market Size, 2018-2029

9.6.2 By Company, China PD-1 and PD-L1 Drug Sales Volume Market Share, 2022

9.6.3 By Type, China PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.6.4 By Application, China PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan PD-1 and PD-L1 Drug Market Size, 2018-2029

9.7.2 By Company, Japan PD-1 and PD-L1 Drug Sales Volume Market Share, 2022

9.7.3 By Type, Japan PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea PD-1 and PD-L1 Drug Market Size, 2018-2029

9.8.2 By Company, South Korea PD-1 and PD-L1 Drug Sales Volume Market Share, 2022

9.8.3 By Type, South Korea PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia PD-1 and PD-L1 Drug Market Size, 2018-2029

9.9.2 By Company, Southeast Asia PD-1 and PD-L1 Drug Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India PD-1 and PD-L1 Drug Market Size, 2018-2029

9.10.2 By Company, India PD-1 and PD-L1 Drug Sales Volume Market Share, 2022

9.10.3 By Type, India PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.10.4 By Application, India PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia PD-1 and PD-L1 Drug Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia PD-1 and PD-L1 Drug Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia PD-1 and PD-L1 Drug Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Bristol Myers Squibb

10.1.1 Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position

10.1.2 Bristol Myers Squibb PD-1 and PD-L1 Drug Models, Specifications and Application

10.1.3 Bristol Myers Squibb PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Bristol Myers Squibb Company Profile and Main Business

10.1.5 Bristol Myers Squibb Recent Developments

10.2 Merck & Co., Inc.

10.2.1 Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position

10.2.2 Merck & Co., Inc. PD-1 and PD-L1 Drug Models, Specifications and Application

10.2.3 Merck & Co., Inc. PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Merck & Co., Inc. Company Profile and Main Business

10.2.5 Merck & Co., Inc. Recent Developments

10.3 F. Hoffmann -La Roche Ltd

10.3.1 F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area and Industry Position

10.3.2 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Models, Specifications and Application

10.3.3 F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 F. Hoffmann -La Roche Ltd Company Profile and Main Business

10.3.5 F. Hoffmann -La Roche Ltd Recent Developments

10.4 AstraZeneca

10.4.1 AstraZeneca Company Information, Head Office, Market Area and Industry Position

10.4.2 AstraZeneca PD-1 and PD-L1 Drug Models, Specifications and Application

10.4.3 AstraZeneca PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 AstraZeneca Company Profile and Main Business

10.4.5 AstraZeneca Recent Developments

10.5 Sanofi

10.5.1 Sanofi Company Information, Head Office, Market Area and Industry Position

10.5.2 Sanofi PD-1 and PD-L1 Drug Models, Specifications and Application

10.5.3 Sanofi PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Sanofi Company Profile and Main Business

10.5.5 Sanofi Recent Developments

10.6 Pfizer Inc

10.6.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position

10.6.2 Pfizer Inc PD-1 and PD-L1 Drug Models, Specifications and Application

10.6.3 Pfizer Inc PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Pfizer Inc Company Profile and Main Business

10.6.5 Pfizer Inc Recent Developments

10.7 Lilly

10.7.1 Lilly Company Information, Head Office, Market Area and Industry Position

10.7.2 Lilly PD-1 and PD-L1 Drug Models, Specifications and Application

10.7.3 Lilly PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Lilly Company Profile and Main Business

10.7.5 Lilly Recent Developments

10.8 Novartis AG

10.8.1 Novartis AG Company Information, Head Office, Market Area and Industry Position

10.8.2 Novartis AG PD-1 and PD-L1 Drug Models, Specifications and Application

10.8.3 Novartis AG PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Novartis AG Company Profile and Main Business

10.8.5 Novartis AG Recent Developments

10.9 GSK

10.9.1 GSK Company Information, Head Office, Market Area and Industry Position

10.9.2 GSK PD-1 and PD-L1 Drug Models, Specifications and Application

10.9.3 GSK PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 GSK Company Profile and Main Business

10.9.5 GSK Recent Developments

10.10 Junshi Biosciences

10.10.1 Junshi Biosciences Company Information, Head Office, Market Area and Industry Position

10.10.2 Junshi Biosciences PD-1 and PD-L1 Drug Models, Specifications and Application

10.10.3 Junshi Biosciences PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Junshi Biosciences Company Profile and Main Business

10.10.5 Junshi Biosciences Recent Developments

10.11 Akeso, Inc

10.11.1 Akeso, Inc Company Information, Head Office, Market Area and Industry Position

10.11.2 Akeso, Inc PD-1 and PD-L1 Drug Models, Specifications and Application

10.11.3 Akeso, Inc PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Akeso, Inc Company Profile and Main Business

10.11.5 Akeso, Inc Recent Developments

10.12 BeiGene

10.12.1 BeiGene Company Information, Head Office, Market Area and Industry Position

10.12.2 BeiGene PD-1 and PD-L1 Drug Models, Specifications and Application

10.12.3 BeiGene PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 BeiGene Company Profile and Main Business

10.12.5 BeiGene Recent Developments

10.13 Innovent

10.13.1 Innovent Company Information, Head Office, Market Area and Industry Position

10.13.2 Innovent PD-1 and PD-L1 Drug Models, Specifications and Application

10.13.3 Innovent PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Innovent Company Profile and Main Business

10.13.5 Innovent Recent Developments

10.14 Jiangsu Hengrui Medicine Co.,Ltd

10.14.1 Jiangsu Hengrui Medicine Co.,Ltd Company Information, Head Office, Market Area and Industry Position

10.14.2 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Models, Specifications and Application

10.14.3 Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Jiangsu Hengrui Medicine Co.,Ltd Company Profile and Main Business

10.14.5 Jiangsu Hengrui Medicine Co.,Ltd Recent Developments

10.15 Cstone

10.15.1 Cstone Company Information, Head Office, Market Area and Industry Position

10.15.2 Cstone PD-1 and PD-L1 Drug Models, Specifications and Application

10.15.3 Cstone PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.15.4 Cstone Company Profile and Main Business

10.15.5 Cstone Recent Developments

10.16 Henlius

10.16.1 Henlius Company Information, Head Office, Market Area and Industry Position

10.16.2 Henlius PD-1 and PD-L1 Drug Models, Specifications and Application

10.16.3 Henlius PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.16.4 Henlius Company Profile and Main Business

10.16.5 Henlius Recent Developments

10.17 Simcere Pharmaceutical Group Limited

10.17.1 Simcere Pharmaceutical Group Limited Company Information, Head Office, Market Area and Industry Position

10.17.2 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Models, Specifications and Application

10.17.3 Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.17.4 Simcere Pharmaceutical Group Limited Company Profile and Main Business

10.17.5 Simcere Pharmaceutical Group Limited Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. PD-1 and PD-L1 Drug Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. PD-1 and PD-L1 Drug Market Restraints

Table 3. PD-1 and PD-L1 Drug Market Trends

Table 4. PD-1 and PD-L1 Drug Industry Policy

Table 5. Global PD-1 and PD-L1 Drug Revenue by Company, 2018-2023, US$ million

Table 6. Global PD-1 and PD-L1 Drug Revenue Market Share by Company, 2018-2023

Table 7. Global PD-1 and PD-L1 Drug Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global PD-1 and PD-L1 Drug Sales Volume Market Share by Company, 2018-2023

Table 9. Global PD-1 and PD-L1 Drug Price by Company, 2018-2023, (US$/Unit)

Table 10. Global PD-1 and PD-L1 Drug Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global PD-1 and PD-L1 Drug Mergers & Acquisitions, Expansion Plans

Table 12. Global PD-1 and PD-L1 Drug Manufacturers Product Type

Table 13. China PD-1 and PD-L1 Drug Revenue by Company, 2018-2023, US$ million

Table 14. China PD-1 and PD-L1 Drug Revenue Market Share by Company, 2018-2023

Table 15. China PD-1 and PD-L1 Drug Sales Volume by Company, 2018-2023, (K Units)

Table 16. China PD-1 and PD-L1 Drug Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, PD-1 and PD-L1 Drug Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China PD-1 and PD-L1 Drug Import & Export Trends

Table 19. Main Sources of China PD-1 and PD-L1 Drug Import

Table 20. Export Destination of China PD-1 and PD-L1 Drug

Table 21. Global Headquarters and Manufacturing Base of PD-1 and PD-L1 Drug Manufacturers

Table 22. Global Major Manufacturers, PD-1 and PD-L1 Drug Capacity Expansion and Future Plans

Table 23. Global PD-1 and PD-L1 Drug Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global PD-1 and PD-L1 Drug Production by Region, 2018-2023, (K Units)

Table 25. Global PD-1 and PD-L1 Drug Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of PD-1 and PD-L1 Drug Upstream (Raw Materials)

Table 27. Global PD-1 and PD-L1 Drug Typical Customers

Table 28. PD-1 and PD-L1 Drug Typical Distributors

Table 29. By Type, Global PD-1 and PD-L1 Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global PD-1 and PD-L1 Drug Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global PD-1 and PD-L1 Drug Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global PD-1 and PD-L1 Drug Revenue, 2018-2029, US$ Million

Table 33. By Region, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global PD-1 and PD-L1 Drug Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global PD-1 and PD-L1 Drug Revenue, 2018-2029, US$ Million

Table 36. By Country, Global PD-1 and PD-L1 Drug Revenue Market Share, 2018-2029

Table 37. By Country, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global PD-1 and PD-L1 Drug Sales Volume Market Share, 2018-2029

Table 39. Bristol Myers Squibb Company Information, Head Office, Market Area and Industry Position

Table 40. Bristol Myers Squibb PD-1 and PD-L1 Drug Models, Specifications and Application

Table 41. Bristol Myers Squibb PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Bristol Myers Squibb Company Profile and Main Business

Table 43. Bristol Myers Squibb Recent Developments

Table 44. Merck & Co., Inc. Company Information, Head Office, Market Area and Industry Position

Table 45. Merck & Co., Inc. PD-1 and PD-L1 Drug Models, Specifications and Application

Table 46. Merck & Co., Inc. PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Merck & Co., Inc. Company Profile and Main Business

Table 48. Merck & Co., Inc. Recent Developments

Table 49. F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area and Industry Position

Table 50. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Models, Specifications and Application

Table 51. F. Hoffmann -La Roche Ltd PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. F. Hoffmann -La Roche Ltd Company Profile and Main Business

Table 53. F. Hoffmann -La Roche Ltd Recent Developments

Table 54. AstraZeneca Company Information, Head Office, Market Area and Industry Position

Table 55. AstraZeneca PD-1 and PD-L1 Drug Models, Specifications and Application

Table 56. AstraZeneca PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. AstraZeneca Company Profile and Main Business

Table 58. AstraZeneca Recent Developments

Table 59. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 60. Sanofi PD-1 and PD-L1 Drug Models, Specifications and Application

Table 61. Sanofi PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Sanofi Company Profile and Main Business

Table 63. Sanofi Recent Developments

Table 64. Pfizer Inc Company Information, Head Office, Market Area and Industry Position

Table 65. Pfizer Inc PD-1 and PD-L1 Drug Models, Specifications and Application

Table 66. Pfizer Inc PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Pfizer Inc Company Profile and Main Business

Table 68. Pfizer Inc Recent Developments

Table 69. Lilly Company Information, Head Office, Market Area and Industry Position

Table 70. Lilly PD-1 and PD-L1 Drug Models, Specifications and Application

Table 71. Lilly PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Lilly Company Profile and Main Business

Table 73. Lilly Recent Developments

Table 74. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 75. Novartis AG PD-1 and PD-L1 Drug Models, Specifications and Application

Table 76. Novartis AG PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Novartis AG Company Profile and Main Business

Table 78. Novartis AG Recent Developments

Table 79. GSK Company Information, Head Office, Market Area and Industry Position

Table 80. GSK PD-1 and PD-L1 Drug Models, Specifications and Application

Table 81. GSK PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. GSK Company Profile and Main Business

Table 83. GSK Recent Developments

Table 84. Junshi Biosciences Company Information, Head Office, Market Area and Industry Position

Table 85. Junshi Biosciences PD-1 and PD-L1 Drug Models, Specifications and Application

Table 86. Junshi Biosciences PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Junshi Biosciences Company Profile and Main Business

Table 88. Junshi Biosciences Recent Developments

Table 89. Akeso, Inc Company Information, Head Office, Market Area and Industry Position

Table 90. Akeso, Inc PD-1 and PD-L1 Drug Models, Specifications and Application

Table 91. Akeso, Inc PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Akeso, Inc Company Profile and Main Business

Table 93. Akeso, Inc Recent Developments

Table 94. BeiGene Company Information, Head Office, Market Area and Industry Position

Table 95. BeiGene PD-1 and PD-L1 Drug Models, Specifications and Application

Table 96. BeiGene PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. BeiGene Company Profile and Main Business

Table 98. BeiGene Recent Developments

Table 99. Innovent Company Information, Head Office, Market Area and Industry Position

Table 100. Innovent PD-1 and PD-L1 Drug Models, Specifications and Application

Table 101. Innovent PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Innovent Company Profile and Main Business

Table 103. Innovent Recent Developments

Table 104. Jiangsu Hengrui Medicine Co.,Ltd Company Information, Head Office, Market Area and Industry Position

Table 105. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Models, Specifications and Application

Table 106. Jiangsu Hengrui Medicine Co.,Ltd PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. Jiangsu Hengrui Medicine Co.,Ltd Company Profile and Main Business

Table 108. Jiangsu Hengrui Medicine Co.,Ltd Recent Developments

Table 109. Cstone Company Information, Head Office, Market Area and Industry Position

Table 110. Cstone PD-1 and PD-L1 Drug Models, Specifications and Application

Table 111. Cstone PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 112. Cstone Company Profile and Main Business

Table 113. Cstone Recent Developments

Table 114. Henlius Company Information, Head Office, Market Area and Industry Position

Table 115. Henlius PD-1 and PD-L1 Drug Models, Specifications and Application

Table 116. Henlius PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 117. Henlius Company Profile and Main Business

Table 118. Henlius Recent Developments

Table 119. Simcere Pharmaceutical Group Limited Company Information, Head Office, Market Area and Industry Position

Table 120. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Models, Specifications and Application

Table 121. Simcere Pharmaceutical Group Limited PD-1 and PD-L1 Drug Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 122. Simcere Pharmaceutical Group Limited Company Profile and Main Business

Table 123. Simcere Pharmaceutical Group Limited Recent Developments

List of Figure

Figure 1. PD-1 and PD-L1 Drug Picture

Figure 2. By Revenue, Global PD-1 and PD-L1 Drug Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global PD-1 and PD-L1 Drug Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global PD-1 and PD-L1 Drug Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China PD-1 and PD-L1 Drug Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China PD-1 and PD-L1 Drug Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China PD-1 and PD-L1 Drug Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China PD-1 and PD-L1 Drug Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China PD-1 and PD-L1 Drug Share of Global Market, 2018-2029

Figure 10. Global PD-1 and PD-L1 Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global PD-1 and PD-L1 Drug Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China PD-1 and PD-L1 Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China PD-1 and PD-L1 Drug Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China PD-1 and PD-L1 Drug Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of PD-1 and PD-L1 Drug Domestic VS Export, 2022

Figure 16. Global PD-1 and PD-L1 Drug Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global PD-1 and PD-L1 Drug Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global PD-1 and PD-L1 Drug Production Market Share & Forecast by Region, 2018-2029

Figure 19. PD-1 and PD-L1 Drug Industry Chain

Figure 20. PD-1 and PD-L1 Drug Procurement Model

Figure 21. PD-1 and PD-L1 Drug Sales Model

Figure 22. PD-1 and PD-L1 Drug Sales Channels, Direct Sales and Distribution

Figure 23. PD-1 Monoclonal Antibody

Figure 24. PD-L1 Monoclonal Antibody

Figure 25. By Type, Global PD-1 and PD-L1 Drug Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global PD-1 and PD-L1 Drug Revenue Market Share, 2018-2029

Figure 27. By Type, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)

Figure 28. By Type, Global PD-1 and PD-L1 Drug Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global PD-1 and PD-L1 Drug Price, 2018-2029, (US$/Unit)

Figure 30. Liver Cancer

Figure 31. Esophageal Cancer

Figure 32. Nasal Cancer

Figure 33. Stomach Cancer

Figure 34. Other

Figure 35. By Application, Global PD-1 and PD-L1 Drug Revenue, 2018-2029, US$ Million

Figure 36. By Application, Global PD-1 and PD-L1 Drug Revenue Market Share, 2018-2029

Figure 37. By Application, Global PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)

Figure 38. By Application, Global PD-1 and PD-L1 Drug Sales Volume Market Share, 2018-2029

Figure 39. By Application, Global PD-1 and PD-L1 Drug Price, 2018-2029, (US$/Unit)

Figure 40. By Region, Global PD-1 and PD-L1 Drug Revenue Market Share, 2018-2029

Figure 41. By Region, Global PD-1 and PD-L1 Drug Sales Volume Market Share, 2018-2029

Figure 42. North America PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 43. By Country, North America PD-1 and PD-L1 Drug Revenue Market Share, 2022

Figure 44. Europe PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 45. By Country, Europe PD-1 and PD-L1 Drug Revenue Market Share, 2022

Figure 46. Asia Pacific PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 47. By Country/Region, Asia Pacific PD-1 and PD-L1 Drug Revenue Market Share, 2022

Figure 48. South America PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 49. By Country, South America PD-1 and PD-L1 Drug Revenue Market Share, 2022

Figure 50. Middle East & Africa PD-1 and PD-L1 Drug Revenue & Forecasts, 2018-2029, US$ Million

Figure 51. U.S. PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)

Figure 52. By Company, U.S. PD-1 and PD-L1 Drug Market Share, 2022

Figure 53. By Type, U.S. PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029

Figure 54. By Application, U.S. PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029

Figure 55. Europe PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)

Figure 56. By Company, Europe PD-1 and PD-L1 Drug Market Share, 2022

Figure 57. By Type, Europe PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029

Figure 58. By Application, Europe PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029

Figure 59. China PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)

Figure 60. By Company, China PD-1 and PD-L1 Drug Market Share, 2022

Figure 61. By Type, China PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029

Figure 62. By Application, China PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029

Figure 63. Japan PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)

Figure 64. By Company, Japan PD-1 and PD-L1 Drug Market Share, 2022

Figure 65. By Type, Japan PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029

Figure 66. By Application, Japan PD-1 and PD-L1 Drug Sales Volume Market Share, 2022 VS 2029

Figure 67. South Korea PD-1 and PD-L1 Drug Sales Volume, 2018-2029, (K Units)

Figure 68. By Company,

Research Methodology:
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Global PD 1 and PD L1 Drug Market Size Estimation

To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.

Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.

Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.

We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.

Data Source

Secondary Sources

This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.

These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.

Market Size
  • Segmental value
  • Geographic Penetration
  • Product Adoption Rate for Different market
  • Journals, Websites, and Press Releases
  • Annual Reports and SEC Filings
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Market Intellix Data Repository
Market Position of Top Company
  • Product Financials
  • Geographic value Mix
  • Total Company value
  • Business/Segmental value Mix
Qualitative Analysis
  • Influence Factors
  • Market Potential
  • Market Risks and Opportunities
  • Industry Trends
  • Geographical Features
  • Government Policies
  • Company Websites and Press Releases
  • Public and Paid Databases
  • Annual Reports
  • Industry Associations
  • Market Intellix Data Repository

Primary Sources

As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.

On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.

These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.

Key Data Information from Primary Sources

Primary Sources Parameters Key Data
Market Segments(by Application, by Type)
  • Value by Type
  • Status and Forecast
  • Value by Application
  • Value by Regions, Status and Forecast (2025-2031)
  • Value Market Share by Type
  • Value Growth Rate by Type
  • Value by Application
  • Percentage and Growth Rate by Application
  • Value Growth Rate and Market Share by Regions
  • Market Size Status and Forecast (2025-2031)
Total Market
  • Overall Size, Status and Forecast
  • Market Size Status and Forecast (2025-2031)
Frequently asked questions(FAQ's):
What is the major concern of the players in the Global PD 1 and PD L1 Drug Market?
As manufacturers prepare to scale up, Global PD 1 and PD L1 Drug companies must be clear and transparent about the impact of such volatility on the balance sheet.
What is the estimated value of the Global PD 1 and PD L1 Drug Market?
The Global PD 1 and PD L1 Drug Market is expected to reach a reasonable valuation by 2030; now the market is expected to shift its focus from growth to value.
In the current situation, what value does the Global PD 1 and PD L1 Drug Market have?
The value of the Global PD 1 and PD L1 Drug Market is estimated to be USD XXX million.
Who should consider the Global PD 1 and PD L1 Drug Market study?
The Global PD 1 and PD L1 Drug Industry stakeholders, executives, and experts, as well as individuals who need to develop consumer-friendly strategies and use technology to stay ahead of the competition.
Company
  • About Us
  • Our Clients
  • Press Releases
  • News
Important Links
  • Terms and Conditions
  • Privacy Policy
  • Help & FAQ
  • Careers
Banking Partners
  • Razorpay
  • Paypal
  • Wire Transfer
Office
S.No. 87/2, 304, Kashid Park, Near Tresor Park, Pune, India, 411207
enquiries@marketintellix[dot]com

Copyright © 2020-2025 - All Rights Reserved | Market Intellix LLP

Sectigo